Type 2 diabetes. Diabetic Retinopathy Risk Calculator
a tool for researchers and health care professionals to prognosticate the risk at diabetes in high risk Australian men who may be treated with testosterone. This score developed from the T4DM trial.<br><br>This is appropriate for men at higher risk risk of developing diabetes, aged 50 to 74 years, waist circumference =95 cm, with impaired glucose tolerance or newly diagnosed type 2 diabetes, and a fasting serum testosterone of =14 nmol/L.<br><br>The risk score is predicting the risk of diabetes at two years, with higher scores indicating higher risk
STDR in the next 5 years (%)
Disclaimer & Privacy
These results provide a guide to inform discussions about diabetic retinopathy risk for your patients.
The results are estimated using data from a group of selected adults with Type 2 diabetes enrolled in Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) clinical trial.Caution should be exercised when interpreting these results as your patients may differ from the FIELD study participants.